Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
129 hedge funds and large institutions have $442M invested in Infinity Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 45 increasing their positions, 50 reducing their positions, and 24 closing their positions.
62% more call options, than puts
Call options by funds: $6.52M | Put options by funds: $4.03M
2.83% more ownership
Funds ownership: 103.34% → 106.17% (+2.8%)
6% less funds holding
Funds holding: 137 → 129 (-8)
10% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 50
21% less capital invested
Capital invested by funds: $557M → $442M (-$115M)
29% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$13.3M |
| 2 |
PA
Pinnacle Associates
New York
|
+$12.4M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$5.44M |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.39M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$3.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$8.25M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$6.44M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$4.04M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.4M |
| 5 |
Renaissance Technologies
New York
|
-$2.96M |
INFI Hedge Fund Activity: Q3 2015 in Review
129 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q3 2015, worth a combined $442M — down 21% from $557M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of INFI and 17 opened new positions — a net loss of 7 holders — while 50 trimmed existing stakes and 45 added.
The largest buyer was Deerfield Management, adding an estimated $13.3M. The largest seller was Numeric Investors, cutting an estimated $8.25M.
- 129 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q3 2015, down from 137 in Q2 2015.
- Funds reported $442M of Infinity Pharmaceuticals, Inc. stock for Q3 2015, down 21% quarter-over-quarter.
- 17 funds opened new Infinity Pharmaceuticals, Inc. positions in Q3 2015 and 24 closed out, a net change of -7 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q3 2015 was Deerfield Management, an estimated $13.3M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q3 2015 was Numeric Investors, an estimated $8.25M sold.
Based on aggregated 13F filings for Q3 2015.